tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Satellos Bioscience (TSE:MSCL)
TSX:MSCL
Canadian Market
MSCL
Satellos Bioscience
RESEARCH TOOLSreports
Advertisement

Satellos Bioscience (MSCL) Stock News & Sentiment

Compare
28 Followers
Satellos Bioscience Advances Phase 2 Trial for Duchenne Muscular Dystrophy Treatment
Premium
Company Announcements
Satellos Bioscience Advances Phase 2 Trial for Duchenne Muscular Dystrophy Treatment
6d ago
Promising Developments and Financial Stability Lead to Buy Rating for Satellos Bioscience
Premium
Ratings
Promising Developments and Financial Stability Lead to Buy Rating for Satellos Bioscience
1M ago
Satellos Bioscience to Engage Investors at September Conferences
Premium
Company Announcements
Satellos Bioscience to Engage Investors at September Conferences
1M ago
Satellos Bioscience Announces Positive Phase 1b Results and Upcoming Clinical Trials for DMD
Premium
Company Announcements
Satellos Bioscience Announces Positive Phase 1b Results and Upcoming Clinical Trials for DMD
2M ago
Satellos Bioscience to Present at Canaccord Genuity’s Growth Conference
Premium
Company Announcements
Satellos Bioscience to Present at Canaccord Genuity’s Growth Conference
2M ago
Satellos Bioscience to Present at Canaccord Genuity’s Growth Conference
Premium
Company Announcements
Satellos Bioscience to Present at Canaccord Genuity’s Growth Conference
2M ago
Satellos Bioscience Appoints Dr. Wildon Farwell as Chief Medical Officer to Advance Neuromuscular Therapies
Premium
Company Announcements
Satellos Bioscience Appoints Dr. Wildon Farwell as Chief Medical Officer to Advance Neuromuscular Therapies
2M ago
More TSE:MSCL News >

MSCL News on the Web

Satellos Bioscience Advances Phase 2 Trial for Duchenne Muscular Dystrophy Treatment
TipRanks News
Neutral
Satellos Bioscience to Present at Canaccord Genuity’s Growth Conference
TipRanks News
Neutral
Satellos Bioscience to Engage with Duchenne Community at PPMD Conference
TipRanks News
Neutral
Satellos Announces Upcoming Presentation at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
Yahoo Finance
Neutral
Satellos concludes MAD cohort enrolment for Phase I trial of SAT-3247
Clinical Trials Arena
Neutral
Satellos Bioscience to Showcase at Oppenheimer Healthcare Conference
TipRanks News
Neutral
Satellos Bioscience Secures $40 Million Funding Boost
TipRanks News
Bullish
Satellos doses first DMD subject in Phase Ib trial
Clinical Trials Arena
Neutral

News Score - Last 7 Days

Neutral
TSE:MSCL
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TSE:MSCL’s Media Buzz Sentiment?
1 articles about TSE:MSCL were published this week. In an average week, 1 articles are published.
    What is TSE:MSCL’s weekly average amount of articles?
    In an average week, 1 articles about TSE:MSCL are published.
      What is TSE:MSCL’s News Sentiment?
      50% of articles about TSE:MSCL were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        COLLCollegium Pharmaceutical
        CDTXCidara Therapeutics
        MBXMBX Biosciences, Inc.
        ACADACADIA Pharmaceuticals
        SAVACassava Sciences
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing